Boehringer Ingelheim

German pharmaceutical company Boehringer Ingelheim has announced plans to invest EUR 500 million in sustainability initiatives and health partnerships. The commitment, disclosed in a company announcement, is aimed at supporting environmental goals and expanding access to healthcare. Details on how the funds will be allocated across projects and partner organisations were not specified in the announcement.